Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blockade in children.

A Kornbluth1, W H Frishman, M Ackerman

  • 1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.

Cardiology Clinics
|November 1, 1987
PubMed
Summary

Beta-adrenergic blockers are frequently prescribed for pediatric patients to manage diverse cardiovascular and noncardiovascular conditions. This review synthesizes clinical experiences with these vital medications in neonates, children, and adolescents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Urticarial eruption in COVID-19 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

AIDS and the heart: Clinicopathologic assessment.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.

Alimentary pharmacology & therapeutics·2015
Same author

Use of video capsule endoscopy in Crohn's disease.

Minerva gastroenterologica e dietologica·2010
Same author

ACE inhibitors and the arterial wall. Introduction.

Postgraduate medicine·2009

Area of Science:

  • Pediatric Pharmacology
  • Cardiovascular Medicine
  • Clinical Therapeutics

Background:

  • Beta-adrenergic blockers are a cornerstone in managing various pediatric health conditions.
  • Their application spans both cardiac and non-cardiac medical issues in young patients.
  • Understanding their use in different pediatric age groups is crucial for effective treatment.

Purpose of the Study:

  • To provide a comprehensive review of clinical experiences with beta-blockers in pediatric populations.
  • To consolidate current knowledge on the use of beta-adrenergic blockers in neonates, children, and adolescents.
  • To serve as a resource for clinicians managing pediatric patients on beta-blocker therapy.

Main Methods:

  • Literature review of clinical studies and case reports.
  • Synthesis of data on beta-blocker efficacy and safety in pediatric age groups.
  • Analysis of therapeutic applications in both cardiovascular and noncardiovascular conditions.

Main Results:

  • Beta-blockers are established treatments for a wide spectrum of pediatric conditions.
  • Clinical data supports their use across neonatal, childhood, and adolescent stages.
  • Evidence highlights the importance of age-specific dosing and monitoring.

Conclusions:

  • Beta-adrenergic blockers are essential therapeutic agents in pediatric medicine.
  • This review underscores the broad utility and established safety profile of beta-blockers in neonates, children, and adolescents.
  • Continued research and clinical vigilance are recommended for optimizing outcomes.

Related Experiment Videos